170 related articles for article (PubMed ID: 34158135)
1. The impact of coronavirus disease 2019 on suspected head and neck cancer two-week-wait referrals.
Bhamra N; Gorman B; Arnold W; Rajah A; Jolly K; Nieto H; Fussey J; Liew L
J Laryngol Otol; 2022 Mar; 136(3):248-251. PubMed ID: 34158135
[TBL] [Abstract][Full Text] [Related]
2. The lasting impact of coronavirus disease 2019 on head and neck cancer services: a UK tertiary centre study.
Taylor R; Khan A; Omakobia E; Sood S
J Laryngol Otol; 2023 May; 137(5):537-540. PubMed ID: 36789959
[TBL] [Abstract][Full Text] [Related]
3. Telephone triage of suspected head and neck cancer patients during the coronavirus disease 2019 pandemic using the Head and Neck Cancer Risk Calculator version 2.
Banerjee S; Voliotidis D; Parvin L; Rama SPK
J Laryngol Otol; 2021 Mar; 135(3):241-245. PubMed ID: 33648611
[TBL] [Abstract][Full Text] [Related]
4. The impact of coronavirus disease 2019 on head and neck cancer services: a UK tertiary centre study.
Taylor R; Omakobia E; Sood S; Glore RJ
J Laryngol Otol; 2020 Aug; 134(8):684-687. PubMed ID: 32758307
[TBL] [Abstract][Full Text] [Related]
5. Coronavirus disease 2019 pandemic telephone two-week-wait referrals in head and neck cancer - how safe were they?
Lau KL; Wilson M; Oozeer N; Cocks H
J Laryngol Otol; 2024 Mar; 138(3):321-324. PubMed ID: 37403606
[TBL] [Abstract][Full Text] [Related]
6. Impact of coronavirus disease 2019 on head and neck urgent suspected cancer referral pathways in rural Wales.
Abelardo E; Gravelle R; Scannell M; Shastri P; Vandekar M; Davies G; Volpini L; Prabhu V
J Laryngol Otol; 2022 Jun; 136(6):540-546. PubMed ID: 35357276
[TBL] [Abstract][Full Text] [Related]
7. A novel remote assessment pathway to streamline the management of two-week-wait suspected head and neck cancer referrals: a prospective analysis of 660 patients.
Metcalfe C; Oh S; Glazzard N; Ross E; George A
J Laryngol Otol; 2024 Jun; 138(6):667-671. PubMed ID: 38369910
[TBL] [Abstract][Full Text] [Related]
8. The impact of coronavirus disease 2019 on the head and neck cancer pathway in the West of Scotland.
Drake I; Rogers A; Stewart M; Montgomery J
J Laryngol Otol; 2022 Jun; 136(6):535-539. PubMed ID: 35225177
[TBL] [Abstract][Full Text] [Related]
9. Remote triage incorporating symptom-based risk stratification for suspected head and neck cancer referrals: A prospective population-based study.
Hardman JC; Tikka T; Paleri V;
Cancer; 2021 Nov; 127(22):4177-4189. PubMed ID: 34411287
[TBL] [Abstract][Full Text] [Related]
10. Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study.
Sud A; Torr B; Jones ME; Broggio J; Scott S; Loveday C; Garrett A; Gronthoud F; Nicol DL; Jhanji S; Boyce SA; Williams M; Riboli E; Muller DC; Kipps E; Larkin J; Navani N; Swanton C; Lyratzopoulos G; McFerran E; Lawler M; Houlston R; Turnbull C
Lancet Oncol; 2020 Aug; 21(8):1035-1044. PubMed ID: 32702311
[TBL] [Abstract][Full Text] [Related]
11. The two-week wait cancer initiative on oral cancer; the predictive value of urgent referrals to an oral medicine unit.
Singh P; Warnakulasuriya S
Br Dent J; 2006 Dec; 201(11):717-20; discussion 714. PubMed ID: 17159958
[TBL] [Abstract][Full Text] [Related]
12. Remote triaging of urgent suspected head and neck cancer referrals: our experience during the first wave of the COVID-19 pandemic.
Kaddour H; Jama GM; Stagnell S; Kaddour S; Guner K; Kumar G
Eur Arch Otorhinolaryngol; 2022 Feb; 279(2):1111-1115. PubMed ID: 34661717
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of urgent suspicion of head and neck cancer referrals in Glasgow.
Douglas CM; Carswell V; Montgomery J
Ann R Coll Surg Engl; 2019 Feb; 101(2):103-106. PubMed ID: 30372125
[TBL] [Abstract][Full Text] [Related]
14. Two week wait referral criteria - heading in the right direction?
Gao C; Qin C; Freeman S; Oskooee N; Hughes J
J Laryngol Otol; 2019 Aug; 133(8):704-712. PubMed ID: 31370911
[TBL] [Abstract][Full Text] [Related]
15. Outcome of two-week head and neck cancer pathway for the otolaryngology department in a tertiary centre.
Mettias B; Charlton A; Ashokkumar S
J Laryngol Otol; 2021 Oct; 135(10):869-873. PubMed ID: 34348805
[TBL] [Abstract][Full Text] [Related]
16. The 2-week rule for suspected head and neck cancer in the United Kingdom: referral patterns, diagnostic efficacy of the guidelines and compliance.
McKie C; Ahmad UA; Fellows S; Meikle D; Stafford FW; Thomson PJ; Welch AR; Paleri V
Oral Oncol; 2008 Sep; 44(9):851-6. PubMed ID: 18234546
[TBL] [Abstract][Full Text] [Related]
17. Audit of referrals for head and neck cancer - the effect of the 2-week, fast track referral system.
Lyons M; Philpott J; Hore I; Watters G
Clin Otolaryngol Allied Sci; 2004 Apr; 29(2):143-5. PubMed ID: 15113298
[TBL] [Abstract][Full Text] [Related]
18. Impact of the '2 week wait' directive for suspected cancer on service provision in a symptomatic breast clinic.
Cant PJ; Yu DS
Br J Surg; 2000 Aug; 87(8):1082-6. PubMed ID: 10931055
[TBL] [Abstract][Full Text] [Related]
19. The two-week wait - a qualitative analysis of suspected head and neck cancer referrals.
Roy S; Anjum K
Br Dent J; 2018 Jul; 225(2):159-163. PubMed ID: 30050208
[No Abstract] [Full Text] [Related]
20. Head and neck cancer waiting times.
Webb CJ; Benton J; Tandon S; Jones TM; Roland NJ
Clin Otolaryngol; 2007 Aug; 32(4):293-6. PubMed ID: 17651275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
